sulfadoxine has been researched along with Symptom Cluster in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, I; Elbashir, MI | 1 |
| Bakkus, MH; Balduck, N; De Raeve, H; Demanet, C; Desprechins, B; Otten, J; Thielemans, K; van der Werff ten Bosch, JE | 1 |
| Arola, M; Azzi, N; Beyaert, R; Boehler, T; Demanet, C; Ferster, A; Laurey, G; Otten, J; Schotte, P; Thielemans, K; van der Werff Ten Bosch, J | 1 |
3 other study(ies) available for sulfadoxine and Symptom Cluster
| Article | Year |
|---|---|
Extrapyramidal syndrome after treatment of falciparum malaria with sulphadoxine-pyrimethamine.
Topics: Adult; Animals; Antimalarials; Basal Ganglia Diseases; Drug Hypersensitivity; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Pyrimethamine; Risk Assessment; Severity of Illness Index; Sulfadoxine; Syndrome | 2004 |
The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency.
Topics: Antimalarials; Autoimmune Diseases; Drug Combinations; fas Receptor; Humans; Infant; Lymphoproliferative Disorders; Pyrimethamine; Sulfadoxine; Syndrome; Tomography, X-Ray Computed | 1998 |
Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations.
Topics: Adolescent; Antimalarials; Apoptosis; Autoimmune Diseases; Case-Control Studies; Caspase 3; Caspases; Cell Division; Cells, Cultured; Child; Cohort Studies; Cytochrome c Group; DNA Mutational Analysis; Drug Combinations; Female; Humans; Infant; Jurkat Cells; Lymphocytes; Lymphoproliferative Disorders; Male; Pyrimethamine; Receptors, Tumor Necrosis Factor; Sulfadoxine; Syndrome | 2002 |